For us, halfway through the 2020s, it’s Mounjaro vs Ozempic, the battle of the fat jabs. In the first ever head-to-head ...

While the drugs certainly contribute to weight loss and health gains, they also cause a decline in muscle that some doctors ...

The Trump administration on Monday singled out powerful new weight-loss drugs including Wegovy and Zepbound as targets in its ...

The popular weight loss medications produced different results in patients who participated in a trial, and here’s what ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Weight loss drugs like Ozempic and Wegovy can reduce alcohol cravings, scientists said, and users have reported drinking less ...

At 72 weeks, participants using Zepbound saw an average weight-loss reduction of 20.2% versus 13.7% with Novo Nordisk’s own ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

By the end of the trial, those who took Zepbound lost about 20% of their body weight on average, compared with a nearly 14% ...